Soros Fund Management’s Surgery Partners SGRY Stock Holding History

Soros Fund Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-133,411	Closed	-$1.99M	–	229
2018 Q2	$1.99M	Sell	133,411 -246,689	-65%	-$4.14M	0.03%	194
2018 Q1	$6.52M	Buy	+380,100	New	+$5.92M	0.11%	145

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.57B AUM 19.49% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Soros Fund Management's SGRY Position: Q3 2018 in Review

Soros Fund Management sold out of Surgery Partners (SGRY) in Q3 2018, closing a stake of 133,411 shares — an estimated $1.99M sold.

Soros Fund Management first reported a position in SGRY in Q1 2018 and held it in 2 quarters. The position peaked at $6.52M in Q1 2018. 79 funds tracked by Wall St. Rank hold SGRY as of Q3 2018.

Soros Fund Management reported no remaining Surgery Partners position as of Q3 2018 after selling out during the quarter.
Soros Fund Management sold 133,411 Surgery Partners shares in Q3 2018, an estimated $1.99M.
Soros Fund Management first reported a position in Surgery Partners in Q1 2018 and held it in 2 quarters.
Soros Fund Management's Surgery Partners position peaked at $6.52M in Q1 2018.
79 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2018.

Based on Soros Fund Management's 13F filing for Q3 2018, filed 14 Nov 2018.